Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAGE-547 Phase 2 in severe postpartum depression
NCT02614547Phase 2Completed
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Start
- Dec 2015
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of brexanolone in postpartum depression (PPD), sponsored by Supernus Pharmaceuticals, Inc.. Started Dec 2015; status: completed.
02
Drugs
brexanolone
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on NCT02614547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02614547.